7737253

Source:http://linkedlifedata.com/resource/pubmed/id/7737253

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0013331, umls-concept:C0030705, umls-concept:C0034656, umls-concept:C0036043, umls-concept:C0149473, umls-concept:C0205179, umls-concept:C0205390, umls-concept:C0332177, umls-concept:C0376358, umls-concept:C0679729, umls-concept:C1257890, umls-concept:C1707877, umls-concept:C1710133
pubmed:dateCreated	1995-6-8
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7512719
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations, http://linkedlifedata.com/resource/pubmed/chemical/Goserelin
pubmed:status	MEDLINE
pubmed:issn	0302-2838
pubmed:author	pubmed-author:DebruyneF MFM, pubmed-author:DijkmanG AGA, pubmed-author:Fernandez del MoralPP, pubmed-author:HoefakkerJ WJW, pubmed-author:IdemaJ GJG, pubmed-author:PlasmanJ WJW, pubmed-author:SykesMM
pubmed:issnType	Print
pubmed:volume	26 Suppl 1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1-2
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:7737253-Delayed-Action Preparations, pubmed-meshheading:7737253-Drug Administration Schedule, pubmed-meshheading:7737253-Goserelin, pubmed-meshheading:7737253-Humans, pubmed-meshheading:7737253-Injections, Subcutaneous, pubmed-meshheading:7737253-Male, pubmed-meshheading:7737253-Prostatic Neoplasms
pubmed:year	1994
pubmed:articleTitle	A phase III randomized trial comparing the efficacy and safety of the 3-monthly 10.8-mg depot of Zoladex with the monthly 3.6-mg depot in patients with advanced prostate cancer. Dutch South East Cooperative Urological Group.
pubmed:affiliation	Department of Urology, St. Ignatius Hospital, Breda, The Netherlands.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Clinical Trial, Phase III